Logo image of B7J1.DE

SRV GROUP OYJ (B7J1.DE) Stock Fundamental Analysis

FRA:B7J1 - Deutsche Boerse Ag - FI4000523675 - Common Stock - Currency: EUR

5.36  +0.16 (+3.08%)

Fundamental Rating

3

B7J1 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 40 industry peers in the Construction & Engineering industry. B7J1 has a bad profitability rating. Also its financial health evaluation is rather negative. B7J1 is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year B7J1 was profitable.
In the past year B7J1 had a positive cash flow from operations.
B7J1 had negative earnings in 4 of the past 5 years.
B7J1 had a positive operating cash flow in 4 of the past 5 years.
B7J1.DE Yearly Net Income VS EBIT VS OCF VS FCFB7J1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of 0.69%, B7J1 is not doing good in the industry: 77.50% of the companies in the same industry are doing better.
B7J1 has a worse Return On Equity (2.11%) than 77.50% of its industry peers.
With a Return On Invested Capital value of 1.70%, B7J1 is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.69%
ROE 2.11%
ROIC 1.7%
ROA(3y)-7.44%
ROA(5y)-5.68%
ROE(3y)-22.94%
ROE(5y)-19.24%
ROIC(3y)N/A
ROIC(5y)N/A
B7J1.DE Yearly ROA, ROE, ROICB7J1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 0.42%, B7J1 is doing worse than 77.50% of the companies in the same industry.
B7J1 has a worse Operating Margin (0.95%) than 77.50% of its industry peers.
B7J1 has a Gross Margin of 13.19%. This is amonst the worse of the industry: B7J1 underperforms 82.50% of its industry peers.
In the last couple of years the Gross Margin of B7J1 has grown nicely.
Industry RankSector Rank
OM 0.95%
PM (TTM) 0.42%
GM 13.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.35%
GM growth 5Y10.78%
B7J1.DE Yearly Profit, Operating, Gross MarginsB7J1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

3

2. Health

2.1 Basic Checks

B7J1 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
B7J1 has about the same amout of shares outstanding than it did 1 year ago.
B7J1 has more shares outstanding than it did 5 years ago.
B7J1 has a better debt/assets ratio than last year.
B7J1.DE Yearly Shares OutstandingB7J1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
B7J1.DE Yearly Total Debt VS Total AssetsB7J1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

B7J1 has an Altman-Z score of 1.91. This is not the best score and indicates that B7J1 is in the grey zone with still only limited risk for bankruptcy at the moment.
B7J1 has a Altman-Z score (1.91) which is in line with its industry peers.
A Debt/Equity ratio of 0.91 indicates that B7J1 is somewhat dependend on debt financing.
B7J1 has a worse Debt to Equity ratio (0.91) than 67.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Altman-Z 1.91
ROIC/WACC0.3
WACC5.75%
B7J1.DE Yearly LT Debt VS Equity VS FCFB7J1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 2.49 indicates that B7J1 has no problem at all paying its short term obligations.
The Current ratio of B7J1 (2.49) is better than 97.50% of its industry peers.
A Quick Ratio of 0.86 indicates that B7J1 may have some problems paying its short term obligations.
The Quick ratio of B7J1 (0.86) is worse than 67.50% of its industry peers.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 0.86
B7J1.DE Yearly Current Assets VS Current LiabilitesB7J1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

5

3. Growth

3.1 Past

B7J1 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.09%, which is quite impressive.
The Revenue has grown by 22.27% in the past year. This is a very strong growth!
The Revenue has been decreasing by -6.81% on average over the past years.
EPS 1Y (TTM)116.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2654.22%
Revenue 1Y (TTM)22.27%
Revenue growth 3Y-7.18%
Revenue growth 5Y-6.81%
Sales Q2Q%15.02%

3.2 Future

Based on estimates for the next years, B7J1 will show a very strong growth in Earnings Per Share. The EPS will grow by 64.47% on average per year.
The Revenue is expected to grow by 3.79% on average over the next years.
EPS Next Y44.9%
EPS Next 2Y85.16%
EPS Next 3Y64.47%
EPS Next 5YN/A
Revenue Next Year0.61%
Revenue Next 2Y4.75%
Revenue Next 3Y4.96%
Revenue Next 5Y3.79%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
B7J1.DE Yearly Revenue VS EstimatesB7J1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M 1B
B7J1.DE Yearly EPS VS EstimatesB7J1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 -5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 29.78 indicates a quite expensive valuation of B7J1.
70.00% of the companies in the same industry are cheaper than B7J1, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of B7J1 to the average of the S&P500 Index (29.35), we can say B7J1 is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 14.66, the valuation of B7J1 can be described as correct.
Based on the Price/Forward Earnings ratio, B7J1 is valued a bit more expensive than the industry average as 65.00% of the companies are valued more cheaply.
B7J1 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 29.78
Fwd PE 14.66
B7J1.DE Price Earnings VS Forward Price EarningsB7J1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
B7J1.DE Per share dataB7J1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

B7J1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as B7J1's earnings are expected to grow with 64.47% in the coming years.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2Y85.16%
EPS Next 3Y64.47%

0

5. Dividend

5.1 Amount

No dividends for B7J1!.
Industry RankSector Rank
Dividend Yield N/A

SRV GROUP OYJ

FRA:B7J1 (3/7/2025, 7:00:00 PM)

5.36

+0.16 (+3.08%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)10-24 2024-10-24/bmo
Earnings (Next)04-23 2025-04-23
Inst Owners26.2%
Inst Owner ChangeN/A
Ins Owners9%
Ins Owner ChangeN/A
Market Cap91.01M
Analysts37.5
Price Target4.97 (-7.28%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.63%
Min Revenue beat(2)1.51%
Max Revenue beat(2)1.76%
Revenue beat(4)4
Avg Revenue beat(4)3%
Min Revenue beat(4)1.51%
Max Revenue beat(4)5.77%
Revenue beat(8)4
Avg Revenue beat(8)-4.02%
Revenue beat(12)5
Avg Revenue beat(12)-4.64%
Revenue beat(16)6
Avg Revenue beat(16)-5.94%
PT rev (1m)-1.84%
PT rev (3m)-4.5%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)29.09%
EPS NY rev (3m)22.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.14%
Revenue NY rev (3m)-2.69%
Valuation
Industry RankSector Rank
PE 29.78
Fwd PE 14.66
P/S 0.12
P/FCF N/A
P/OCF 82.74
P/B 0.62
P/tB 0.63
EV/EBITDA N/A
EPS(TTM)0.18
EY3.36%
EPS(NY)0.37
Fwd EY6.82%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)0.06
OCFY1.21%
SpS43.93
BVpS8.65
TBVpS8.52
PEG (NY)0.66
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.69%
ROE 2.11%
ROCE 2.41%
ROIC 1.7%
ROICexc 1.97%
ROICexgc 1.99%
OM 0.95%
PM (TTM) 0.42%
GM 13.19%
FCFM N/A
ROA(3y)-7.44%
ROA(5y)-5.68%
ROE(3y)-22.94%
ROE(5y)-19.24%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.35%
GM growth 5Y10.78%
F-Score7
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 0.35%
Interest Coverage 0.92
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 0.86
Altman-Z 1.91
F-Score7
WACC5.75%
ROIC/WACC0.3
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.38%
Cap/Sales(5y)0.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2654.22%
EPS Next Y44.9%
EPS Next 2Y85.16%
EPS Next 3Y64.47%
EPS Next 5YN/A
Revenue 1Y (TTM)22.27%
Revenue growth 3Y-7.18%
Revenue growth 5Y-6.81%
Sales Q2Q%15.02%
Revenue Next Year0.61%
Revenue Next 2Y4.75%
Revenue Next 3Y4.96%
Revenue Next 5Y3.79%
EBIT growth 1Y617.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year107.41%
EBIT Next 3Y42.14%
EBIT Next 5Y20.48%
FCF growth 1Y-17.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.29%
OCF growth 3Y-74.82%
OCF growth 5YN/A